Zepbound® Weight Loss Program

Name: Zepbound® Weight Loss Program
Brand: Arsynl
Price: 99.00 USD
Availability: InStock

Zepbound® (tirzepatide injection) is the newest FDA-approved GLP-1 medication, targeting both GLP-1 and GIP to help you achieve your weight loss and health goals.

For $99/mo, our comprehensive program includes virtual provider visits, personalized health coaching, lab access, and continuous support. Medication not included.

Fast free delivery

U.S. board certified physicians

Trusted medications, money back guarantee

$99.00 USD

Start Your Zepbound® Prescription Online

Your Arsynl membership covers the doctor visit and pharmacy prescription. Medication ships directly from and is billed by LillyDirect.

The 5 Easy Steps to get Zepbound from Arsynl

1. Click “Add To Cart” above and complete the checkout.

2. Join the Arsynl Membership for Weight Loss— pay $99 per month for ongoing care.

3. The Arsynl medical team reviews your info within 24 hours and, if approved, e-prescribes Zepbound from LillyDirect.

4. LillyDirect contacts you for payment ($349 per month for 2.5 mg; $499 for higher doses) and ships your medication.

5. All Zepbound is sold, billed, and shipped exclusively by LillyDirect.

HOW TO (FINALLY) GET LEAN

Tired of fighting a losing battle? Zepbound® has your back—helping you take charge of your body and goals.

Shreds stubborn fat
Helps lower BMI
Regulates insulin levels
Supports lower blood pressure
Trims waistline

How it works

Step - 1

Take the health questionnaire

⌄

100% online and confidential health intake form

Step - 2

Get your prescription

⌄

All prescriptions overseen by fully licensed and insured physicians

Step - 3

Get your meds

⌄

Fast free delivery from our accredited pharmacies

Why choose ARSYNL Rx Telemedicine?

US-licensed professionals

Experienced healthcare providers committed to your well-being.

No insurance needed

Upfront pricing, with no hidden fees.

Ongoing medical support

Ongoing assistance with your specific health condition

Frequently asked questions

Zepbound uses the same active ingredient (tirzepatide) as Mounjaro®. It’s a dual-action GLP-1/GIP-receptor agonist that is approved by the FDA for people with obesity, or overweight plus a weight-related condition, along with diet and exercise changes.

Zepbound and Wegovy are approved by the FDA for weight loss, while Ozempic is approved for the treatment of type 2 diabetes, but can be prescribed off-label for weight loss, if appropriate.

The main difference between these medications is the active ingredient. Ozempic and Wegovy use semaglutide, while Zepbound uses tirzepatide. Tirzepatide is a dual-action GLP-1 and GIP, meaning it works by activating two receptors to curb nausea and regulate your metabolism, helping you feel full faster and longer. In comparison, semaglutide only activates the GLP-1 receptor.